In surprise decision, US approves muscular dystrophy drug – CNBC

0
1022
In surprise decision, US approves muscular dystrophy drug – CNBC

U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here